Attributable healthcare utilization and cost of pneumonia due to drug-resistant streptococcus pneumonia: A cost analysis

Antimicrobial Resistance and Infection Control

Volumn 3, Issue 1, 2014, Pages

  Reynolds, Courtney A ^a   Finkelstein, Jonathan A ^b,c   Ray, G T ^d   Moore, Matthew R ^e   Huang, Susan S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d DIVISION OF RESEARCH   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Antibiotic resistance; DRSP; Healthcare utilization; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; ERYTHROMYCIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; CHILD; COST BENEFIT ANALYSIS; DRUG COST; DRUG MEGADOSE; HEALTH CARE COST; HEALTH CARE DISPARITY; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; INFANT; INFECTION CONTROL; LOW DRUG DOSE; MAJOR CLINICAL STUDY; NONHUMAN; OUTPATIENT CARE; PRIORITY JOURNAL; PRODUCTIVITY; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

EID: 84910670192     PISSN: None     EISSN: 20472994     Source Type: Journal    
DOI: 10.1186/2047-2994-3-16     Document Type: Article

References (24)

1. Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. J Am Med Assoc 1993, 270:1826-1831.
2. Shapiro ED, Berg AT, Austrian R, Schroeder D, Parcells V, Margolis A, Adair RK, Clemens JD. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991, 325(21):1453-1460. 10.1056/NEJM199111213252101, 1944423.
3. Centers for Disease Control and Prevention (CDC) Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine - United States, 1997-2006. MMWR Morb Mortal Wkly Rep 2009, 8(01):1-4. Centers for Disease Control and Prevention (CDC).
4. Lexau CA, Lynfield R, Danila R, Pilishvili T, Facklam R, Farley MM, Harrison LH, Schaffner W, Reingold A, Bennett NM, Hadler J, Cieslak PR, Whitney CG, . Active Bacterial Core Surveillance Team Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. J Am Med Assoc 2005, 294:2043-2051. Active Bacterial Core Surveillance Team.
5. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH, Schuchat A, . Active Bacterial Core Surveillance of the Emerging Infections Program Network Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003, 348(18):1737-1746. 10.1056/NEJMoa022823, 12724479, Active Bacterial Core Surveillance of the Emerging Infections Program Network.
6. Mokaddas E, Albert MJ. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait. Vaccine 2012, 30(Suppl 6):G37-G40.
7. Mueller JE, Yaro S, Ouedraogo MS, Levina N, Njanpop-Lafourcade BM, Tall H, Idohou RS, Sanou O, Kroman SS, Drabo A, Nacro B, Millogo A, van der Linden M, Gessner BD. Pneumococci in the African meningitis belt: meningitis incidence and carriage prevalence in children and adults. PLoS One 2012, 7(12):e52464. 10.1371/journal.pone.0052464, 3527509, 23285051.
8. Muhammed RD, Oza-Frank R, Zell E, Link-Gelles R, Narayan KM, Schaffner W, Thomas A, Lexau C, Bennett NM, Farley MM, Harrison LH, Reingold A, Hadler J, Beall B, Klugman KP, Moore MR. Epidemiology of invasive pneumococcal disease among high-risk adults since the introduction of pneumococcal conjugate vaccine for children. Clin Infect Dis 2013, 56(5):e59-e67. 10.1093/cid/cis971, 23155149.
9. Rosselli D, Rueda JD. Burden of pneumococcal infection in adults in Colombia. J Infect Public Health 2012, 5(5):354-359. 10.1016/j.jiph.2012.04.003, 23164564.
10. Al Musawi M. A retrospective epidemiological study of invasive pneumococcal infections in children aged 0-5 years in Bahrain from 1 January 1999 to 31 December 2003. Vaccine 2012, 30(Suppl 6):G2-G6.
11. Huang SS, Johnson KM, Ray GT, Wroe P, Lieu TA, Moore MR, Zell ER, Linder JA, Grijalva CG, Metlay JP, Finkelstein JA. Healthcare utilization and cost of pneumococcal disease in the United States. Vaccine 2011, 29:3398-3412. 10.1016/j.vaccine.2011.02.088, 21397721.
12. Centers for Disease Control and Prevention 2013 Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Streptococcus pneumoniae. 2011, http://www.cdc.gov/abcs/reports-findings/survreports/spneu11.pdf, Centers for Disease Control and Prevention 2013.
13. Jackson LA, Janoff EN. Pneumococcal vaccination of elderly adults: new paradigms for protection. Clin Infect Dis 2008, 47(10):1328-1338. 10.1086/592691, 18844484.
14. Simonsen L, Taylor RJ, Young-Xu Y, Haber M, May L, Klugman KP. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. MBio 2011, 2(1):e00309-e00310. 3025524, 21264063.
15. Song JH, Dagan R, Klugman KP, Fritzell B. The relationship between pneumococcal serotypes and antibiotic resistance. Vaccine 2012, 30(17):2728-2737. 10.1016/j.vaccine.2012.01.091, 22330126.
16. Hicks LA, Chien YW, Taylor TH, Haber M, Klugman KP, . on behalf of the Active Bacterial Core Surveillance (ABCs) Team Outpatient antibiotic prescribing and nonsusceptible streptococcus pneumoniae in the United States, 1996-2003. Clin Infect Dis 2011, 53(7):631-639. 10.1093/cid/cir443, 21890767, on behalf of the Active Bacterial Core Surveillance (ABCs) Team.
17. Hanage WP, Bishop CJ, Huang SS, Stevenson AE, Pelton SI, Lipsitch M, Finkelstein JA. Carried pneumococci in Massachusetts children: the contribution of clonal expansion and serotype switching. Pediatr Infect Dis J 2011, 30(4):302-308. 10.1097/INF.0b013e318201a154, 3175614, 21085049.
18. Weinberger DM, Malley R, Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. Lancet 2011, 378(9807):1962-1973. 10.1016/S0140-6736(10)62225-8, 3256741, 21492929.
19. Wroe PC, Lee GM, Finkelstein JA, Pelton SI, Hanage WP, Lipsitch M, Stevenson AE, Rifas-Shiman SL, Kleinman K, Dutta-Linn MM, Hinrichsen VL, Lakoma M, Huang SS. Pneumococcal carriage and antibiotic resistance in young children before 13-valent conjugate vaccine. Pediatr Infect Dis J 2013, 31(3):249-254.
20. Hanage WP, Bishop CJ, Lee GM, Lipsitch M, Stevenson A, Rifas-Shiman SL, Pelton SI, Huang SS, Finkelstein JA. Clonal replacement among 19A streptococcus pneumoniae in Massachusetts, prior to 13 valent conjugate vaccination. Vaccine 2011, 29(48):8877-8881. 10.1016/j.vaccine.2011.09.075, 3221484, 21964059.
21. Lee GM, Kleinman K, Pelton SI, Hanage W, Huang SS, Lakoma M, Dutta-Linn M, Croucher NJ, Stevenson A, Finkelstein JA. Impact of PCV13 vaccination on streptococcus pneumoniae carriage in young children in Massachusetts. J Pediatr Infect Dis Soc 2014, 3(1):23-32.
22. Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan SL, Mace SE, McCracken GH, Moore MR, St Peter SD, Stockwell JA, Swanson JT, . Pediatric Infectious Diseases Society and the Infectious Diseases Society of America The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the pediatric infectious diseases society and the infectious diseases society of America. Clin Infect Dis 2011, 53(7):617-630. 10.1093/cid/cir625, 3202323, 21890766, Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.
23. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM, Musher DM, Niederman MS, Torres A, Whitney CG, . Infectious Diseases Society of America; American Thoracic Society Infectious diseases society of America/American thoracic society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 44(Suppl 2):S27-S72. Infectious Diseases Society of America; American Thoracic Society.
24. Hanage WP, Kaijalainen TH, Syrjanen RK, Auranen K, Leinonen M, Makela PH, Spratt BG. Invasiveness of serotypes and clones of streptococcus pneumoniae among children in Finland. Infect Immun 2005, 73(1):431-435. 10.1128/IAI.73.1.431-435.2005, 538975, 15618181.